Pain Management Therapeutics Market Size, Share, Growth Analysis, By Drug class(Opioids, NSAIDs, anticonvulsants, anesthetics), By Indication(Arthritic pain, chronic back pain, cancer pain, neuropathic pain), By Distribution channel(Online pharmacy, hospital pharmacy, and retail pharmacy), By Region - Industry Forecast 2024-2031

Pain Management Therapeutics Market size was valued at USD 75976 million in 2019 and is poised to grow from USD 78711.14 million in 2023 to USD 104451.39 million by 2031, growing at a CAGR of 3.6% in the forecast period (2024-2031).

Most physicians and other medical professionals provide some pain control in the course of their procedure, including more complex cases of pain, they seek additional assistance from pain medicine, a medical specialty devoted to pain. Pain management frequently employs a multidisciplinary approach to alleviate suffering and improve quality of life for anyone suffering from pain, whether acute or chronic. Analgesia (pain relief) in general is frequently an acute affair, whereas managing chronic pain necessitates additional dimensions. Furthermore, pain management therapeutics are becoming more popular as a result of their use in the treatment of a diverse range of medical conditions, such as fibromyalgia, neuropathic pain, chronic back pain, arthritic pain, post-operative pain, cancer pain, and migraine. However, the loss of power, influence, and funding by pain advocacy organisations is also predicted to slow market growth. Advocacy groups for pain management are losing their initial power and influence as a result of funding cuts from the government and sponsors, which would include pharmaceutical companies.

US Pain Management Therapeutics Market is poised to grow at a sustainable CAGR for the next forecast year.